NY Medical Cannabis Assoc Suing State For $US20 Million Over “Special Licensing Fee” | Cannabis Law Report | How to order Skittles Moonrock online

Learn how to order marijuana online. TOP QUALITY GRADE A++

Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.

👉 Click here to Visit our shop! 🛒

MJ Biz

A group representing licensed medical marijuana operators in New York is suing the state over a $20 million “special licensing fee” that the lawsuit calls “punitive and unconstitutional.”

The suit is the latest in a string of legal challenges that have contributed to a shaky rollout of New York’s recreational cannabis industry.

The lawsuit, filed by the New York Medical Cannabis Industry Association (NYMCIA) in the State Supreme Court in Albany, alleges that the Office of Cannabis Management and Cannabis Control Board “overstepped their authority, subverted the intention of the state Legislature in the 2021 Marihuana Regulation And Taxation Act (MRTA) and assessed a punitive tax in the guise of a special licensing fee,” according to a news release.

The MRTA, signed into law in March 2021, was intended to provide licensing opportunities and support to social equity applicants and microbusinesses.

The lawsuit seeks to invalidate the “special licensing fee” because it:

• “Violates the separation of powers doctrine.
• “Constitutes an impermissible tax in the guise of an administrative fee.
• “Violates the Equal Protection and Takings Clauses of the New York Constitution.“

Defendants named in the suit are:

• The New York State Office of Cannabis Management (OCM).
• The New York State Cannabis Control Board (CCB).
• CCB Chair Tremaine Wright.
• OCM Executive Deputy Director and Acting Executive Director Felicia Reid.

The NYMCIA alleges in its suit that a regulation requiring MMJ operators seeking to enter the state’s adult-use market to pay $20 million in four payments is “so onerous that it has decimated their enterprise value, amounting to a ‘regulatory taking’” of their business.

Read their full report